InvestorsHub Logo
Followers 7
Posts 566
Boards Moderated 0
Alias Born 12/03/2013

Re: twiz0019 post# 16978

Wednesday, 07/02/2014 8:48:37 AM

Wednesday, July 02, 2014 8:48:37 AM

Post# of 48316
I'm not sure they have much "evidence" to present because of their choices of words. But I agree this is a start in a good direction IMO.

Data will be presented supporting the TIL-dependent responder hypothesis and the potential of intratumoral therapies to enhance immunogenicity. The future role of intratumoral therapies in driving a de novo TIL response and potentially converting PD-1 mAb non-responders into responders will be discussed.